Navigation Links
Vaginal reconstruction not needed for most inter-sex females, Hopkins study shows
Date:10/27/2007

Dispelling a common myth, researchers from the Johns Hopkins Childrens Center say vaginal reconstruction should be a matter of preference for most teens or adult women born with a type of inter-sex condition marked by the presence of both female and male genitals. The findings of the research are being presented at the American Academy of Pediatrics Conference Oct. 26 through Oct. 30 in San Francisco.

Women with complete androgen insensitivity are born with relatively shallow vaginas that may or may not require surgical repair and with undescended testes that do require removal.

Vaginal surgery, if needed or wanted, should be done after puberty, when physical development is complete and a girl or a woman is mature enough to make a decision, researchers say.

It is a common misconception in the general public and quite often among doctors that most girls born with this condition should have vaginal reconstruction in order to be sexually active, says lead investigator Todd Purves, M.D. Ph.D., a urologist at Hopkins Childrens. Our findings show that, on the contrary, most young women choose not to have the surgery, have vaginal depths that are within normal parameters and can lead active sexual lives.

In their study of 29 women born with the syndrome, researchers found that 38 percent chose to have vaginal surgery. Comparing those who had surgery with those who did not, researchers found that both groups had similar rates of sexual activity: Eighty percent of those who chose not to have surgery were sexually active, compared to 70 percent of those who had surgery.

As surgeons, we need to make sure that the parents of babies with this disorder understand that their daughter may not even need vaginal surgery, and if she does, it is a decision that should wait until after adolescence, Purves says.

Gender identity in women born with this condition is almost always female.


'/>"/>

Contact: Katerina Pesheva
epeshev1@jhmi.edu
410-926-6780
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1

Related biology news :

1. Vaginal gel may provide a new approach to HIV prevention
2. UCSF study will test new vaginal microbicide for herpes and HIV
3. Fat stem cells being studied as option for breast reconstruction
4. Tissue engineering for craniofacial reconstruction
5. A much-needed shot in the arm for HIV vaccine development
6. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
7. Clear rules needed to govern deep sea bioprospecting: UNU
8. Quick identification needed to save Floridas citrus industry from devastating disease
9. Womb needed for proper brain development
10. Molecular research suggest shift needed in how some drugs are created
11. Gene needed for butterfly transformation also key for insects like grasshoppers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/4/2017)... 4, 2017  For the thousands of attendees at this year,s International ... connected health and biometric measurement devices and services, will be featuring its ... display in A&D Medical,s special CES Exhibit Suite , the new ... of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... MILPITAS, Calif. , Jan. 17, 2017 /PRNewswire/ ... today announced that it has initiated a global ... PTG-100, an oral peptide that targets alpha4beta7 integrin. ... design study is to evaluate the safety/tolerability and ... colitis patients with moderate to severe active disease. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court of New Jersey ... appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company (DPCL) for its ... of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary Dishman USA located ...
(Date:1/16/2017)... ... January 16, 2017 , ... Attagene , a ... the U.S. Small Business Administration. The Tibbetts Award honors the Small Business ... […] and are considered the best of the best from the thousands of ...
(Date:1/14/2017)... ... January 14, 2017 , ... ... providing complete end-to-end genome assemblies to researchers around the globe. Long considered ... obstacle in answering a wide range of scientific questions. The announcement was ...
Breaking Biology Technology: